Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome
LGVN Stock | USD 2.05 0.01 0.49% |
About 56% of all Longeveron LLC's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Longeveron LLC suggests that some traders are interested. Longeveron LLC's investing sentiment overview a quick insight into current market opportunities from investing in Longeveron LLC. Many technical investors use Longeveron LLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Longeveron |
Wael Hashad Wael Hashad, CEO, Longeveron On-going Phase 2b clinical trial deemed pivotal and, if positive, acceptable for Biological License Application submission for potential full traditional approvalAlignment with FDA on ELPIS II primary and secondary endpointsAlignment with FDA on CMC and Potency Assay plan and requirements MIAMI, Sept. 03, 2024 -- Longeveron Inc. , a clinical stage regenerative medicine biotechnology company developing cell
Read at finance.yahoo.com
Longeveron LLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Longeveron LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Longeveron LLC Fundamental Analysis
We analyze Longeveron LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longeveron LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longeveron LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Longeveron LLC is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Longeveron LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longeveron LLC stock to make a market-neutral strategy. Peer analysis of Longeveron LLC could also be used in its relative valuation, which is a method of valuing Longeveron LLC by comparing valuation metrics with similar companies.
Peers
Longeveron LLC Related Equities
SRZN | Surrozen | 19.37 | ||||
FBRX | Forte Biosciences | 9.70 | ||||
CCCC | C4 Therapeutics | 8.59 | ||||
KTTA | Pasithea Therapeutics | 6.55 | ||||
GBIO | Generation Bio | 6.29 | ||||
ABVC | ABVC Biopharma | 3.92 | ||||
EWTX | Edgewise Therapeutics | 2.48 | ||||
QNRX | Quoin Pharmaceuticals | 1.69 | ||||
BOLT | Bolt Biotherapeutics | 1.59 | ||||
REVB | Revelation Biosciences | 1.33 | ||||
KZR | Kezar Life | 0.95 | ||||
RNXT | RenovoRx | 0.79 | ||||
INDP | Indaptus Therapeutics | 0.97 | ||||
NTRB | Nutriband | 1.03 | ||||
KRON | Kronos Bio | 1.04 | ||||
KROS | Keros Therapeutics | 1.38 | ||||
ERAS | Erasca | 2.05 | ||||
LRMR | Larimar Therapeutics | 4.67 | ||||
VRAX | Virax Biolabs | 4.83 | ||||
KPRX | Kiora Pharmaceuticals | 8.68 |
Check out Longeveron LLC Hype Analysis, Longeveron LLC Correlation and Longeveron LLC Performance. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longeveron LLC. If investors know Longeveron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longeveron LLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.62) | Revenue Per Share 0.364 | Quarterly Revenue Growth 1.157 | Return On Assets (0.62) | Return On Equity (1.42) |
The market value of Longeveron LLC is measured differently than its book value, which is the value of Longeveron that is recorded on the company's balance sheet. Investors also form their own opinion of Longeveron LLC's value that differs from its market value or its book value, called intrinsic value, which is Longeveron LLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longeveron LLC's market value can be influenced by many factors that don't directly affect Longeveron LLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longeveron LLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longeveron LLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longeveron LLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.